American Heart Journal·8 AugHPS-4/TIMI 65/ORION-4: A double-blind randomized placebo-controlled trial assessing the effects of inclisiran on clinical outcomes among people with atherosclerotic cardiovascular disease: Trial design, recruitment, and baseline characteristicsTrial in peopleInterventionsPaper
AAIC 2025 Abstract·26 DecEffect of amyloid, tau and syndromic stages of Alzheimer's disease (AD) in speech markers: A potential scalable tool for screening in AD clinical trialsStudy in peopleBiomarkersPaper